A commonly-prescribed drug, Avandia, for type 2 diabetes, may increase the risk of brittle bone disease, say researchers.

Diabetes drug link to weak bones

Extract from BBC News:

"A commonly-prescribed drug for type 2 diabetics may increase the risk of brittle bone disease, say researchers.

Tests on mice found that rosiglitazone (Avandia), which is used to boost the effects of insulin, could be interfering with new bone formation."